QuantRx Biomedical Corporation
QTXB · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $7 | $24 | $4 | $7 |
| SG&A Expenses | $7 | $27 | $4 | $7 |
| Sales & Mktg Exp. | $0 | $3 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $7 | $27 | $4 | $7 |
| Operating Income | -$7 | -$27 | -$4 | -$7 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$54 | -$54 | -$54 | -$54 |
| Pre-Tax Income | -$61 | -$81 | -$57 | -$61 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$61 | -$81 | -$57 | -$61 |
| % Margin | – | – | – | – |
| EPS | -0.001 | -0.001 | -0.001 | -0.001 |
| % Growth | 20% | -42.9% | 12.5% | – |
| EPS Diluted | -0.001 | -0.001 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 78,696 | 78,696 | 78,696 | 78,696 |
| Weighted Avg Shares Out Dil | 78,696 | 78,696 | 78,696 | 78,696 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $54 | $54 | $54 | $54 |
| Depreciation & Amortization | $7 | $27 | $4 | $7 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |